byiShook Opinion
May 7, 2025 - 12:35
Sarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical FDA appointment. The post The 'Double Whammy' That Sent Sarepta Stock To An Eight-Year Low appeared first on Investor's Business Daily.
Sarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical FDA appointment.
The post The 'Double Whammy' That Sent Sarepta Stock To An Eight-Year Low appeared first on Investor's Business Daily.